Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Biospecifics Technologies Corp. market cap is $650.25M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Biospecifics Technologies Corp. 52 week high is $89.15 as of September 25, 2023.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Biospecifics Technologies Corp. 52 week low is $42.00 as of September 25, 2023.
Biospecifics Technologies Corp. stock price yesterday was $88.53.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Biospecifics Technologies Corp.’s P/E ratio is 37.55.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Biospecifics Technologies Corp. P/B ratio is 4.8054.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Biospecifics Technologies Corp. 50-day moving average is $76.94.
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.